Myhr KM - Search Results

1

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T. Løken-Amsrud KI, et al. Among authors: myhr km. PLoS One. 2013;8(1):e54417. doi: 10.1371/journal.pone.0054417. Epub 2013 Jan 22. PLoS One. 2013. PMID: 23349882 Free PMC article.

2

Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway.

Myhr KM, Frost P, Grønning M, Midgard R, Kalland KH, Helland DE, Nyland HI. Myhr KM, et al. Acta Neurol Scand. 1994 Jan;89(1):65-8. doi: 10.1111/j.1600-0404.1994.tb01634.x. Acta Neurol Scand. 1994. PMID: 8178631

3

Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway.

Nyland H, Myhr KM, Lillås F, Smievoll AI, Riise T, Nortvedt M, Nilsen R. Nyland H, et al. Among authors: myhr km. Mult Scler. 1996 Jul;1(6):372-5. doi: 10.1177/135245859600100618. Mult Scler. 1996. PMID: 9345420 Clinical Trial.

4

Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Myhr KM, Riise T, Green Lilleås FE, Beiske TG, Celius EG, Edland A, Jensen D, Larsen JP, Nilsen R, Nortvedt MW, Smievoll AI, Vedeler C, Nyland HI. Myhr KM, et al. Neurology. 1999 Mar 23;52(5):1049-56. doi: 10.1212/wnl.52.5.1049. Neurology. 1999. PMID: 10102427 Clinical Trial.

5

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients.

Nordvik I, Myhr KM, Nyland H, Bjerve KS. Nordvik I, et al. Among authors: myhr km. Acta Neurol Scand. 2000 Sep;102(3):143-9. doi: 10.1034/j.1600-0404.2000.102003143.x. Acta Neurol Scand. 2000. PMID: 10987373 Clinical Trial.

6

Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.

Myhr KM, Riise T, Vedeler C, Nortvedt MW, Grønning R, Midgard R, Nyland HI. Myhr KM, et al. Mult Scler. 2001 Feb;7(1):59-65. doi: 10.1177/135245850100700110. Mult Scler. 2001. PMID: 11321195

7

[New diagnostic criteria in multiple sclerosis].

Midgard R, Beiske AG, Celius EG, Jensen D, Hovdal H, Mellgren SI, Myhr KM. Midgard R, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 2003 May 15;123(10):1345-8. Tidsskr Nor Laegeforen. 2003. PMID: 12806674 Review. Norwegian. No abstract available.

8

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.

Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R. Dahl OP, et al. Among authors: myhr km. Acta Neurol Scand. 2004 Jun;109(6):378-84. doi: 10.1111/j.1600-0404.2004.00244.x. Acta Neurol Scand. 2004. PMID: 15147459

9

[Optic neuritis--diagnosis, treatment and follow up].

Midgard R, Seland JH, Hovdal H, Celius EG, Eriksen K, Jensen D, Heger H, Mellgren SI, Wexler A, Beiske AG, Myhr KM. Midgard R, et al. Among authors: myhr km. Tidsskr Nor Laegeforen. 2005 Feb 17;125(4):425-8. Tidsskr Nor Laegeforen. 2005. PMID: 15742012 Free article. Retracted. Norwegian.

10

Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple sclerosis.

Beiske AG, Myhr KM. Beiske AG, et al. Among authors: myhr km. J Neurol. 2006 Mar;253(3):377-8. doi: 10.1007/s00415-006-0898-0. Epub 2006 Mar 6. J Neurol. 2006. PMID: 16502214 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page